Gain Therapeutics, Inc.Gain Therapeutics, Inc.Gain Therapeutics, Inc.

Gain Therapeutics, Inc.

No trades
See on Supercharts

GANX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
GANX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company